These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1340442)

  • 21. [Pulse methylprednisolone therapy in children with idiopathic thrombocytopenic purpura].
    Ohtsuka Y; Toku Y; Maeda H; Ohmiya A; Mori K; Fukuda T; Yanai M; Tsuji Y
    Rinsho Ketsueki; 1988 Apr; 29(4):488-93. PubMed ID: 3043039
    [No Abstract]   [Full Text] [Related]  

  • 22. Pilot study of the pharmacokinetics of methylprednisolone after single and multiple intravenous doses of methylprednisolone sodium succinate and methylprednisolone suleptanate to healthy volunteers.
    Ferry JJ; Della-Coletta AA; Weber DJ; VanderLugt JT
    J Clin Pharmacol; 1994 Nov; 34(11):1109-15. PubMed ID: 7876403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of intravenous methylprednisolone and oral prednisone in paediatric patients with inflammatory bowel disease during the acute phase and in remission.
    Faure C; André J; Pelatan C; Munck A; Giraud M; Cèzard JP; Jacqz-Aigrain E
    Eur J Clin Pharmacol; 1998 Sep; 54(7):555-60. PubMed ID: 9832298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD4+/CD8+ lymphocyte patterns in renal transplant recipients receiving chronic methylprednisolone.
    Tornatore KM; Reed K; Venuto RC
    J Med; 1993; 24(2-3):98-112. PubMed ID: 8105017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylprednisolone disposition in renal transplant recipients receiving triple-drug immunosuppression.
    Tornatore KM; Morse GD; Jusko WJ; Walshe JJ
    Transplantation; 1989 Dec; 48(6):962-5. PubMed ID: 2595785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of methylprednisolone as prophylaxis for immediate adverse infusion reactions in hypogammaglobulinaemic patients receiving intravenous immunoglobulin: a controlled trial.
    Roberton DM; Hosking CS
    Aust Paediatr J; 1988 Jun; 24(3):174-7. PubMed ID: 3048235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis.
    Bannwarth B; Péhourcq F; Schaeverbeke T; Dehais J
    Clin Pharmacokinet; 1996 Mar; 30(3):194-210. PubMed ID: 8882301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disposition of pulse dose methylprednisolone in adult and paediatric patients with the nephrotic syndrome.
    Assael BM; Banfi G; Appiani AC; Edefonti A; Jusko WJ
    Eur J Clin Pharmacol; 1982; 23(5):429-33. PubMed ID: 7151847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I clinical trial and pharmacokinetic study of the spicamycin analog KRN5500 administered as a 1-hour intravenous infusion for five consecutive days to patients with refractory solid tumors.
    Supko JG; Eder JP; Ryan DP; Seiden MV; Lynch TJ; Amrein PC; Kufe DW; Clark JW
    Clin Cancer Res; 2003 Nov; 9(14):5178-86. PubMed ID: 14613997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time-variant increase in methylprednisolone clearance in patients with acute respiratory distress syndrome: a population pharmacokinetic study.
    Yates CR; Vysokanov A; Mukherjee A; Ludden TM; Tolley E; Meduri GU; Dalton JT
    J Clin Pharmacol; 2001 Apr; 41(4):415-24. PubMed ID: 11304898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose methylprednisolone sodium succinate (pulse therapy) in the treatment of renal disease: plasma and urine concentrations.
    Searle M; Lawson G; Chakraborty J; Baylis EM; Lee HA; Marks V
    Eur J Clin Pharmacol; 1985; 28(3):245-8. PubMed ID: 3891379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies of methotrexate pharmacokinetics in children with neoplasms of the hematopoietic system after administration of different doses of the drug].
    Wysocki M; Krzyzanowski M; Ozyński T; Pilecki O; Balcar-Boroń A; Szadujkis-Szadurski L
    Acta Haematol Pol; 1992; 23(3):179-83. PubMed ID: 1492542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cortisol pharmacodynamic response to long-term methylprednisolone in renal transplant recipients.
    Tornatore KM; Reed K; Walshe JJ; Venuto RC
    Pharmacotherapy; 1994; 14(1):111-8. PubMed ID: 8159595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High dose oral methylprednisolone in patients with rheumatoid arthritis: pharmacokinetics and clinical response.
    Hayball PJ; Cosh DG; Ahern MJ; Schultz DW; Roberts-Thomson PJ
    Eur J Clin Pharmacol; 1992; 42(1):85-8. PubMed ID: 1541321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous pulse methylprednisolone treatment of juvenile dermatomyositis.
    Laxer RM; Stein LD; Petty RE
    Arthritis Rheum; 1987 Mar; 30(3):328-34. PubMed ID: 3566824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High dose intravenous methylprednisolone "pulse" therapy in patients with rheumatoid disease. Plasma methylprednisolone levels and adrenal function.
    Baylis EM; Williams IA; English J; Marks V; Chakraborty J
    Eur J Clin Pharmacol; 1982; 21(5):385-8. PubMed ID: 7042371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of methylprednisolone and rejection episodes in kidney transplant patients.
    Keller F; Hemmen T; Schöneshöfer M; Schwarz A; Offermann G
    Transplantation; 1995 Aug; 60(4):330-3. PubMed ID: 7652760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid method for the measurement of methylprednisolone and its hemisuccinate in plasma and urine following "pulse therapy" by high-performance liquid chromatography.
    Lawson GJ
    J Chromatogr; 1985 Aug; 342(2):251-60. PubMed ID: 3902861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of gestodene and ethinylestradiol in 14 women during three months of treatment with a new tri-step combination oral contraceptive: serum protein binding of gestodene and influence of treatment on free and total testosterone levels in the serum.
    Kuhnz W; Baumann A; Staks T; Dibbelt L; Knuppen R; Jütting G
    Contraception; 1993 Oct; 48(4):303-22. PubMed ID: 8222659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.